PubMed:23864035 25 Projects
Annnotations
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_23864035_1_0 | 144-154 | expanded | denotes | Bortezomib |
| SS2_23864035_1_0 | 156-160 | abbr | denotes | bort |
| SS1_23864035_1_2 | 210-229 | expanded | denotes | relapsed/refractory |
| SS2_23864035_1_2 | 231-234 | abbr | denotes | R/R |
| SS1_23864035_1_1 | 236-252 | expanded | denotes | multiple myeloma |
| SS2_23864035_1_1 | 254-256 | abbr | denotes | MM |
| SS1_23864035_9_0 | 1329-1354 | expanded | denotes | progression-free survival |
| SS2_23864035_9_0 | 1356-1359 | abbr | denotes | PFS |
| SS1_23864035_9_1 | 1365-1381 | expanded | denotes | overall survival |
| SS2_23864035_9_1 | 1383-1385 | abbr | denotes | OS |
| AE1_23864035_1_0 | SS1_23864035_1_0 | SS2_23864035_1_0 | abbreviatedTo | Bortezomib,bort |
| AE1_23864035_1_1 | SS1_23864035_1_1 | SS2_23864035_1_1 | abbreviatedTo | multiple myeloma,MM |
| AE1_23864035_1_2 | SS1_23864035_1_2 | SS2_23864035_1_2 | abbreviatedTo | relapsed/refractory,R/R |
| AE1_23864035_9_0 | SS1_23864035_9_0 | SS2_23864035_9_0 | abbreviatedTo | progression-free survival,PFS |
| AE1_23864035_9_1 | SS1_23864035_9_1 | SS2_23864035_9_1 | abbreviatedTo | overall survival,OS |